In a significant development for health tech security, Evinova has achieved the globally recognized ISO 27001 certification, reinforcing its commitment to AI data security and clinical data protection. The certification, aligned with the 2022 version of the standard, validates that Evinova’s information security management systems meet rigorous international benchmarks for safeguarding sensitive information.
The Evinova ISO certification arrives at a time when the healthcare and life sciences sectors are increasingly reliant on digital platforms and AI-driven solutions. As cyber threats continue to evolve, achieving ISO 27001 certification signals that the company adheres to best practices in identifying, managing, and mitigating risks associated with data handling.
ISO 27001 certification validates AI data security approach
The ISO 27001 certification underscores Evinova’s approach to embedding AI data security into its product ecosystem, particularly as its solutions intersect with clinical trial design and patient data. According to company leadership, the certification reflects a unified focus on innovation and security, indicating that technological advancement and cybersecurity are being treated as equally critical priorities.
Senior executives highlighted that the Evinova ISO certification provides assurance to pharmaceutical partners and stakeholders that the infrastructure supporting its AI-native tools is built with stringent security controls. Industry experts note that this is especially important as digital health platforms increasingly integrate with external data sources, raising the stakes for clinical data protection.
Clinical data protection becomes industry priority
The growing emphasis on clinical data protection has made certifications like ISO 27001 certification essential for companies operating in the health technology space. Analysts suggest that organizations handling sensitive patient and research data must demonstrate robust governance frameworks to maintain trust and regulatory compliance.
Evinova’s leadership indicated that its cybersecurity strategy has been a core focus since inception, with dedicated efforts to implement policies, controls, and cultural practices aligned with global standards. Experts in healthcare cybersecurity observe that such proactive measures are becoming a baseline expectation rather than a competitive advantage.
British Standards Institution issues certification
The Evinova ISO certification was formally issued by British Standards Institution, a globally recognized authority in standards and certification. This endorsement further strengthens the credibility of Evinova’s health tech security framework and its ability to maintain compliance in a highly regulated environment.
Quality and compliance leaders within the company emphasized that the certification demonstrates a strong alignment between its information security management system and broader quality management processes. This integration is seen as critical in ensuring continuous compliance and operational transparency.
Health tech security landscape evolves rapidly
The broader health tech security landscape is undergoing rapid transformation, driven by the adoption of AI, digital trials, and real-time data analytics. The ISO 27001 certification positions Evinova to navigate this evolving environment while maintaining high standards of AI data security and clinical data protection.
Industry observers suggest that the Evinova ISO certification could set a precedent for other health technology firms aiming to build trust in an increasingly data-driven ecosystem. As cyber risks grow more complex, adherence to internationally recognized standards is likely to remain a key differentiator.